It is the 70th anniversary of the World Health Day and WHO is calling to World leaders to live up to the pledges they made when they agreed to the Sustainable Development Goals in 2015, and commit to concrete steps for #HealthForAll. This means ensuring that everyone, everywhere can access essential quality ...
Read More »
Gene therapy continues to evolve with new emerging treatments finally reaching its promised potential: providing a one-time lifelong cure for even the rarest and most severe of genetic disorders. TIF’s Expert Advisor, Dr. Carsten Werner Lederer, explores this critical issue in his article, by highlighting the recent conditional approval for ...
Read More »
World Hemophilia Day is an international awareness day for hemophilia and other bleeding disorders. It is held annually on April 17, date of the birthday of Frank Schnabel, founder of the World Federation of Hemophilia. Since 1989, World Hemophilia Day is the day the whole bleeding disorders community comes together ...
Read More »
This is how this year’s voting results were shaped: Universal access to quality thalassaemia healthcare services: Building bridges with and for patients (Winning theme, 196 votes) Patients’ voice at the frontline: Advocating for a better future in thalassaemia care and management (112 votes) The globalization of thalassaemia – Common challenges ...
Read More »
ANNOUNCEMENT: Dear friends and esteemed collaborators, The Thalassaemia International Federation (TIF) since its establishment in 1986 has been a pioneer in providing the patients’ perspective in all health-related areas including policy-making, research, clinical trials, drug development etc, in a transparent manner, as laid out by its Code of ...
Read More »
The Egyptian Thalassaemia Association (ETA), in celebration of this year’s International Thalassaemia Day, is organizing the 20th International Thalassaemia Day Conference to be held in Cairo on May, 1-2, 2019. Renowned international and national scientists working in the field, among which Dr. Frempong, one of the pioneers of sickle ...
Read More »
The European Medicines Agency (EMA) has published a booklet describing the journey of a medicine for human use authorised through EMA, from initial research to discussions on patient access to medicines across the EU. The booklet’s title is ”From laboratory to patient: the journey of a centrally authorised medicine” ...
Read More »
At TIF we believe that well-informed patients are able to gain in-depth understanding of their condition and make purposeful decisions about their health! That being so, we are pleased to announce that registrations for the upcoming 6th class of its Thal e-Course for patients are now open! You can access the registration form here 👉 http://bit.ly/2BVkX9c
Read More »
TIF
